The Multiple Facets of Thrombotic Microangiopathies

Chairperson:

Pier Mannuccio Mannucci¹

Speakers:

Paul Coppo,² Javier de la Rubia,³ Thorsten Feldkamp⁴

1. Cà Granda Maggiore Policlinico Hospital Foundation, Milan, Italy 
2. Hôpital Saint-Antoine, Paris, France 
3. Hospital La Fe, Valencia, Spain 
4. University Hospital Schleswig Holstein, Christian-Albrechts-University, Kiel, Germany

Disclosure:

Prof de la Rubia declares speaker fees, consultancy, funding support or sponsorship from Alexion Pharma International. Prof Coppo declares speaker fees, consultancy, funding support, sponsorship, or stocks/shares from Alexion Pharma International, Roche International, and Baxter International. Prof Feldkamp has received speaker fees, consultancy, funding support, or sponsorship from Alexion Pharma International and Novartis. Prof Mannucci received speaker fees from Alexion.

Acknowledgements:

Writing assistance provided by Dr Saroshi Amirthalingam, ApotheCom ScopeMedical.

Support:

The publication of this article was funded by Alexion Pharma International. The views and opinions expressed are those of the authors and not necessarily of Alexion.

Citation:

EMJ Hema. 2014;1[1]:50-58. DOI/10.33590/emjhematol/10310448. https://doi.org/10.33590/emjhematol/10310448.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.